|
1
|
Bradley J and Movsas B: Radiation
esophagitis: predictive factors and preventive strategies. Semin
Radiat Oncol. 14:280–286. 2004. View Article : Google Scholar
|
|
2
|
Byhardt RW, Scott C, Sause WT, et al:
Response, toxicity, failure patterns and survival in five RTOG
trails of sequential and/or concurrent chemotherapy and
radiotherapy for locally advanced non-small-cell carcinoma of the
lung. Int J Radiat Oncol Biol Phys. 42:469–478. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abdel-Latif MM, Duggan S, Reynolds JV and
Kelleher D: Inflammation and esophageal carcinogenesis. Curr Opin
Pharmacol. 9:396–404. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu YF, Yu HM, Zhang C, Cheng YF, Hu LK,
Meng XH and Zhao YX: Protective effects of berberine on
radiation-induced lung injury via intercellular adhesion
molecular-1 and transforming growth factor-beta-1 in patients with
lung cancer. Eur J Cancer. 44:2425–2432. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Goodlad RA and Wright NA: Epidermal growth
factor (EGF). Baillieres Clin Gastroenterology. 10:33–47. 1996.
View Article : Google Scholar
|
|
6
|
Fatimah SS, Tan GC, Chua KH, Tan AE and
Hayati AR: Effects of epidermal growth factor on the proliferation
and cell cycle regulation of cultured human amnion epithelial
cells. J Biosci Bioeng. 114:220–227. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pohlers D, Brenmoehl J, Löffler I, et al:
TGF-beta and fibrosis in different organs - molecular pathway
imprints. Biochim Biophys Acta. 1792:746–756. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Delanian S and Lefaix JL: The
radiation-induced fibroatrophic process: therapeutic perspective
via the antioxidant pathway. Radiother Oncol. 73:119–131. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Barcellos-Hoff MH: How do tissues respond
to damage at the cellular level? The role of cytokines in
irradiated tissues. Radiat Res. 150:109–120. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Martin M, Lefaix JL and Delanian S:
TGF-beta1 and radiation fibrosis: a master switch and a specific
therapeutic target? Int J Radiat Oncol Biol Phys. 47:277–290. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kosaka Y, Mitsumori M, Araki N, et al:
Avascular necrosis of bilateral femoral head as a result of
long-term steroid administration for radiation pneumonitis after
tangential irradiation of the breast. Int J Clin Oncol. 11:482–486.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hou W and Zhou YM: Function of traditional
chinese medicine in cancer radiotherapy and its prospect. Mode
Tradit Chin Med Mater Med. 11:742–746. 2009.
|
|
13
|
Zhang P and Hu PL: TCM VVM Therapy’s
influence on tumor patients’ survival. Chin J Oncol.
25:3022003.
|
|
14
|
Shen L, Shan BE, Zhang L, et al: The
experimental research of compound of White Pony Root Oral Liquid on
radiation-induced esophagitis. J Radiol Prot. 27:219–227. 2007.
|
|
15
|
Hallahan DE: Radiation-mediated gene
expression in the pathogenesis of the clinical radiation response.
Semin Radiat Oncol. 6:250–267. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Somosy Z: Radiation response of cell
organelles. Micron. 31:165–181. 2000. View Article : Google Scholar
|
|
17
|
Falcieri E, Gobbi P, Zamai L and Vitale M:
Ultrastructural features of apoptosis. Scan Microsc. 8:653–666.
2000.
|
|
18
|
Payne CM, Bjore CG and Schultz DA: Change
in the frequency of apoptosis after low- and high-dose
X-irradiation of human lymphocytes. J Leukoc Biol. 52:433–440.
1992.PubMed/NCBI
|
|
19
|
Barnard JA, Beauchamp RD, Russell WE, et
al: Epidermal growth factor-related peptides and their relevance to
gastrointestinal pathophysiology. Gastroenterology. 108:564–580.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Garner A: Therapeutic potential of growth
factors and their antagonists. Yale J Biol Med. 65:715–723.
1992.PubMed/NCBI
|
|
21
|
Gibbs S, Silva Pinto AN, Murli S, Huber M,
Hohl D and Ponec M: Epidermal growth factor and keratinocyte growth
factor differentially regulate epidermal migration, growth, and
differentiation. Wound Repair Regen. 8:192–203. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Reuter S, Gupta SC, Chaturvedi MM and
Aggarwal B: Oxidative stress, inflammation, and cancer: How are
they linked? Free Radical Bio Med. 49:1603–1616. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rodemann HP and Marcel AB: Responses of
normal cells to ionizing radiation. Semin Radiat Oncol. 17:81–88.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fournier C, Scholz M, Kraft-Weyrather W,
et al: Changes of fibrosis-related parameters after high- and
low-LET irradiation of fibroblasts. Int J Radiat Biol. 77:713–722.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rodemann HP and Bamberg M: Cellular basis
of radiation-induced fibrosis. Radiother Oncol. 35:83–90. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Border WA and Noble NA: Transforming
growth factor beta in tissue fibrosis. N Engl J Med. 331:1286–1292.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schultze-Mosgau S, Blaese MA, Grabenbauer
G, Wehrhan F, et al: Smad-3 and Smad-7 expression following
antitransforming growth factor beta 1 (TGFbeta1)-treatment in
irradiated rat tissue. Radiother Oncol. 70:249–259. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
McGinnis WL, Loprinzi CL, Buskirk SJ, et
al: Placebo-controlled trail of sucralfate for inhibiting
radiation-induced esophagitis. J Clin Oncol. 15:1239–1243.
1997.PubMed/NCBI
|
|
29
|
Movsas B, Scott C, Langer C, et al: Phase
III study of amifostine in patients with locally advanced non-small
cell lung cancer (NSCLC) receiving chemotherapy and
hyperfractionated radiation (Chemo/HFxRT): Radiation Therapy
Oncology Group (RTOG) 98-01 (abstract 2559). Proc Am Soc Clin
Oncol. 22:6362003.
|
|
30
|
Steen VD, Medsger TA Jr and Rodnan GP:
D-penicillamine therapy in progressive systemic sclerosis. Ann
Intern Med. 97:652–659. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tsushima H, Kawata S, Tanura S, et al:
Reduced plasma transforming growth factor-beta1 levels in patients
with chronic hepatitis C after interferon alpha therapy:
association with regression of hepatic fibrosis. J Hepatol. 30:1–7.
1999. View Article : Google Scholar
|
|
32
|
Vozenin-Brotons MC, Sivan V, Gault N, et
al: Anti-fibrotic action of Cu/Zn SOD is mediated by TGF-beta1
repression and phenotypic reversion of myofibroblasts. Free Radic
Biol Med. 30:30–42. 2001. View Article : Google Scholar : PubMed/NCBI
|
